StonvexLoading…
StonvexCore line items from MOS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $12.05B | $11.12B | $13.70B | $19.13B |
Operating Income | $821.50M | $621.50M | $1.34B | $4.79B |
Net Income | $540.70M | $174.90M | $1.16B | $3.58B |
EPS (Diluted) | $1.70 | $0.55 | $3.50 | $10.06 |
Total Assets | $24.48B | $22.92B | $23.03B | $23.39B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $276.60M | $272.80M | $348.80M | $735.40M |
Free Cash Flow OCF − CapEx | $-534.60M | $47.40M | $1.00B | $2.69B |
Shares Outstanding | 317.41M | 316.93M | 324.10M | 339.07M |